145 results
6-K
EX-99.1
QGEN
Qiagen NV
30 Apr 24
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
5:58pm
Officer of QIAGEN.
"As we move on from the pandemic, we are steadfast in our commitment to driving innovation given our ongoing high level of R&D investments … compared to 67.3% in Q1 2023 amid initiatives to improve production capacity utilization. R&D investments were 11.2% of sales in Q1 2024 compared 11.3
6-K
QGEN
Qiagen NV
8 Feb 24
Current report (foreign)
9:47am
with a high level of R&D investments, while also increasing returns through a $300 million synthetic share repurchase that underscores our commitment … in 2023 by lower capacity utilization and adverse product mix changes. R&D investments remained at a high level and steady at 9.0% of sales in Q4 2023
6-K
EX-99.1
QGEN
Qiagen NV
23 Jan 24
QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million
12:00am
, pharma R&D and industrial applications, primarily forensics). As of September 30, 2023, QIAGEN employed more than 6,000 people in over 35 locations
6-K
EX-99.1
QGEN
Qiagen NV
8 Jan 24
QIAGEN announces plans to return approximately $300 million to shareholders
9:59am
healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). Further information can be found at http
6-K
o03g4 h1t
31 Oct 23
Current report (foreign)
7:51pm
6-K
pxmid 6dtausup9kne8b
31 Oct 23
Current report (foreign)
7:09pm
6-K
EX-99.7
zfszbf 9vpwvmjff
31 Oct 23
Notice of the Annual General Meeting of Shareholders
6:58pm
6-K
pzm2vir
9 Aug 23
Current report (foreign)
9:55pm
6-K
vnikey927 cv68
9 Aug 23
Current report (foreign)
9:40pm
6-K
j9w zufjsq
4 May 23
Current report (foreign)
9:26pm
6-K
sxdnxp9 c4hd
4 May 23
Current report (foreign)
9:19pm
6-K
kcfy3d swepn2u
8 Nov 22
Current report (foreign)
7:44pm
6-K
8tq vr1dz0b
8 Nov 22
Current report (foreign)
7:21pm
6-K
95dzqbz4h 2edrr4y3ps
8 Nov 22
Current report (foreign)
6:49pm
6-K
elcum3
28 Jul 22
Current report (foreign)
7:01pm
6-K
qzl5eseww6
27 Jul 22
Current report (foreign)
7:39pm
6-K
cdkrjowv98
28 Apr 22
Current report (foreign)
5:38pm
6-K
asw fgsqol2i66ume1e
27 Apr 22
Current report (foreign)
7:54pm